Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$875K Buy
440
+195
+80% +$310K 0.02% 186
2026
Q1
$324K Buy
245
+25
+11% +$34.3K 0.01% 268
2025
Q4
$235K Buy
+220
New +$229K 0.01% 305
2025
Q1
Sell
-376
Closed -$261K 289
2024
Q4
$261K Buy
+376
New +$270K 0.01% 250
2024
Q3
Sell
-201
Closed -$206K 293
2024
Q2
$206K Sell
201
-112
-36% -$108K 0.01% 270
2024
Q1
$304K Sell
313
-1
-0.3% -$887 0.01% 242
2023
Q4
$238K Buy
+314
New +$207K 0.01% 272

Other funds holding ASML

Aspiriant LLC's ASML Position: Q2 2026 in Review

Aspiriant LLC increased its ASML (ASML) stake by 80% in Q2 2026, buying an estimated $310K and bringing the position to 440 shares worth $875K. The position accounts for 0.02% of the portfolio, ranked #186.

Aspiriant LLC first reported a position in ASML in Q4 2023 and has held it in 7 quarters since. 604 funds tracked by Wall St. Rank hold ASML as of Q2 2026.

  • Aspiriant LLC held 440 shares of ASML worth $875K as of Q2 2026.
  • Aspiriant LLC bought 195 ASML shares in Q2 2026, an estimated $310K.
  • ASML made up 0.02% of Aspiriant LLC's portfolio in Q2 2026, its #186 holding.
  • Aspiriant LLC first reported a position in ASML in Q4 2023 and has held it in 7 quarters since.
  • 604 funds tracked by Wall St. Rank held ASML as of Q2 2026.

Based on Aspiriant LLC's 13F filing for Q2 2026, filed 20 Jul 2026.